Venlafaxine for major depression
- PMID: 17272528
- PMCID: PMC1790758
- DOI: 10.1136/bmj.39098.457720.BE
Venlafaxine for major depression
Abstract
More evidence that risks outweigh benefits for most patients?
Conflict of interest statement
Comment in
-
Suicidal and self harming behaviours may be distinct.BMJ. 2007 Feb 17;334(7589):327. doi: 10.1136/bmj.39121.857569.1F. BMJ. 2007. PMID: 17303844 Free PMC article. No abstract available.
Comment on
-
Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.BMJ. 2007 Feb 3;334(7587):242. doi: 10.1136/bmj.39041.445104.BE. Epub 2006 Dec 12. BMJ. 2007. PMID: 17164297 Free PMC article.
References
-
- Rubino A, Roskell N, Tennis P, Mines D, Weich S, Andrews E. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ 2007. doi:10.1136/bmj.39041.445104.BE - DOI - PMC - PubMed
-
- Smith D, Dempster C, Glanville J, Freemantle N, Anderson I. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 2002;180:396-404. - PubMed
-
- Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005;143:415-26. - PubMed
-
- Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol 2005;20:59-69. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources